Compliance News Roundup: PHI Used in Marketing

1. Philadelphia-Area Doctor Pleads Guilty to Unlawfully Distributing Oxycodone - Richard Ira Mintz, D.O., 69, of Dresher, Pennsylvania, pleaded guilty to eight counts of distributing controlled substances outside the scope of professional practice and not for a legitimate medical purpose before U.S. District Court Judge Michael M. Baylson of the Eastern District of Pennsylvania. Sentencing is scheduled for Sept. 11. Get the full scoop >>

2. New London Psychiatrist and Mental Health Clinic Pay over $3.3 Million to Settle False Claims Act Allegations – “United States Attorney John H. Durham, Special Agent in Charge Phillip Coyne of the U.S. Department of Health and Human Services, Office of Inspector General, and Connecticut Attorney General William Tong today announced that Dr. Bassam AWWA and his medical practice, Connecticut Behavioral Health Associates, P.C. (“CBHA”) have entered into a civil settlement agreement with the federal and state governments in which they will pay $3,382,004 to resolve allegations that they violated the federal and state False Claims Acts.” Get the full scoop >>

3. Deeper Than the Headlines: PHI for Marketing – Have you ever received some promotional or marketing material from a hospital you visited? How about from a pharmacy, physician’s office or nursing home? Well, the HIPAA Privacy Rule allows your personal information to be used for marketing purposes under certain circumstances, but ultimately, you as the patient have control over whether and how your protected health information is used and disclosed for marketing purposes [45 CFR 164.501, 164.508(a)(3)]. HHS OCR provides guidance on marketing in the context of HIPAA. Get the full scoop >>

Questions or Comments?